Soleus Capital Management, L.P.

Holdings History for Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Symbol: RVNC
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2021		-0.16%	$0	0	-31,136	-100%	$3.65	Q2 2021
31 Mar 2021	0.16%	0%	$870,000	31,136	0		$27.94	Q1 2021
31 Dec 2020	0.24%	-0.08%	$882,000	31,136	-10,481	-25%	$28.33	Q4 2020
30 Sep 2020	0.55%	+0.18%	$1,046,000	41,617	+13,148	+46%	$25.13	Q3 2020
30 Jun 2020	0.42%	+0.25%	$695,000	28,469	+16,600	+140%	$24.41	Q2 2020
31 Mar 2020	0.2%	-0.2%	$176,000	11,869	-11,331	-49%	$14.83	Q1 2020
31 Dec 2019	0.36%	0%	$376,000	23,200	0		$16.21	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.